How can we best optimize pharmacotherapy for patients with Type 2 diabetes? What are the main treatment barriers to keep in mind, and what are the most common comorbidities that we might be able to treat concurrently with diabetes therapy? Dr. Susan Cornell, assistant professor of pharmacy practice at Midwestern University Chicago College of Pharmacy, takes a closer look at these questions, and also shares strategies to directly collaborate with diabetic patients in managing the consequences of their disease. Dr. Charles Turck hosts.
Facebook Comments